| NAME |
INTERFERON BETA-1A,RECOMBINANT 30 MCG/VIL INJ |
| VA GENERIC NAME |
INTERFERON BETA-1A |
| DOSAGE FORM |
INJ,LYPHL |
| FDA MED GUIDE |
Interferon_beta-1a_syr-pen_(Avonex)_(2021).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
30 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2020-04-15 00:00:00 |
| UNITS |
MCG/VIL |
| DSS NUMBER |
1 |
| NATIONAL FORMULARY NAME |
INTERFERON BETA-1A INJ,LYPHL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
INTERFERON BETA-1A 30MCG/VIL INJ(AVONEX) |
| VA PRODUCT IDENTIFIER |
I0338 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
VI |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4012898 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
-
- 2020-04-15 00:00:00
- STATUS: INACTIVE
|
